BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 11775783)

  • 1. Immunization against Haemophilus influenzae type b in Sweden--a study of the introduction process.
    Garpenholt O; Fredlund H; Timpka T
    Scand J Public Health; 2001 Dec; 29(4):271-8. PubMed ID: 11775783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NTAGI subcommittee recommendations on Haemophilus influenzae type B (Hib) vaccine introduction in India.
    Subcommittee on Introduction of Hib Vaccine in Universal Immunization Program, National Technical Advisory Group on Immunization, India
    Indian Pediatr; 2009 Nov; 46(11):945-54. PubMed ID: 19955578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of vaccines on pneumonia: key lessons from Haemophilus influenzae type b conjugate vaccines.
    Gessner BD; Adegbola RA
    Vaccine; 2008 Jun; 26 Suppl 2():B3-8. PubMed ID: 18793604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hib returns.
    Edwards A
    Minn Med; 2009 Mar; 92(3):35-6. PubMed ID: 19400384
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of non-routine vaccination on the incidence of invasive Haemophilus influenzae type b (Hib) disease: experience in the autonomous region of Valencia, Spain.
    Díez-Domingo J; Pereiró I; Morant A; Gimeno C; San-Martín M; González A;
    J Infect; 2001 May; 42(4):257-60. PubMed ID: 11545568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of Haemophilus influenzae type B vaccination in Indonesia: a cost-effectiveness analysis.
    Broughton EI
    J Public Health (Oxf); 2007 Dec; 29(4):441-8. PubMed ID: 17875589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introducing new vaccines in developing countries: concepts and approaches to estimating burden of Haemophilus influenzae type b-associated disease.
    Kilgore PE; Nyambat B
    J Health Popul Nutr; 2004 Sep; 22(3):246-56. PubMed ID: 15609777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epiglottitis in Sydney before and after the introduction of vaccination against Haemophilus influenzae type b disease.
    Wood N; Menzies R; McIntyre P
    Intern Med J; 2005 Sep; 35(9):530-5. PubMed ID: 16105154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive Haemophilus influenzae type b disease in Sweden 1997-2003: epidemiological trends and patterns in the post-vaccine era.
    Farhoudi D; Löfdahl M; Giesecke J
    Scand J Infect Dis; 2005; 37(10):717-22. PubMed ID: 16191888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hib vaccine: should it be introduced in the national immunization program?
    Taneja DK
    Indian J Public Health; 2012; 56(3):177-9. PubMed ID: 23229207
    [No Abstract]   [Full Text] [Related]  

  • 11. Haemophilus influenzae type b vaccine in Papua New Guinea: what can we expect, and how should we determine priority for child health interventions?
    Duke T
    P N G Med J; 1999; 42(1-2):1-4. PubMed ID: 11061000
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of the introduction of a combined Haemophilus B conjugate vaccine and hepatitis B recombinant vaccine on vaccine coverage rats in a large West Coast health maintenance organization.
    Davis RL; Coplan P; Mell L; Black S; Shinefield H; Lewis E
    Pediatr Infect Dis J; 2003 Jul; 22(7):657-8. PubMed ID: 12886895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive infections caused by haemophilus influenzae serotypes in twelve Canadian IMPACT centers, 1996-2001.
    McConnell A; Tan B; Scheifele D; Halperin S; Vaudry W; Law B; Embree J;
    Pediatr Infect Dis J; 2007 Nov; 26(11):1025-31. PubMed ID: 17984810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia.
    Gessner BD; Sedyaningsih ER; Griffiths UK; Sutanto A; Linehan M; Mercer D; Mulholland EK; Walker DG; Steinhoff M; Nadjib M
    Pediatr Infect Dis J; 2008 May; 27(5):438-43. PubMed ID: 18398383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ongoing control of Haemophilus influenzae type B infections in Canadian children, 2004-2007.
    Scheifele DW; Bettinger JA; Halperin SA; Law B; Bortolussi R
    Pediatr Infect Dis J; 2008 Aug; 27(8):755-7. PubMed ID: 18594482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.
    Lee YC; Kelly DF; Yu LM; Slack MP; Booy R; Heath PT; Siegrist CA; Moxon RE; Pollard AJ
    Clin Infect Dis; 2008 Jan; 46(2):186-92. PubMed ID: 18171249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-to-date Haemophilus influenzae type b vaccination coverage during a vaccine shortage.
    White KE; Pabst LJ; Cullen KA
    Pediatrics; 2011 Mar; 127(3):e707-12. PubMed ID: 21339271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive Haemophilus influenzae Type B disease in five young children--Minnesota, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Jan; 58(3):58-60. PubMed ID: 19177041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemophilus influenzae meningitis 5 years after introduction of the Haemophilus influenzae type b conjugate vaccine in Brazil.
    Ribeiro GS; Lima JB; Reis JN; Gouveia EL; Cordeiro SM; Lobo TS; Pinheiro RM; Ribeiro CT; Neves AB; Salgado K; Silva HR; Reis MG; Ko AI
    Vaccine; 2007 May; 25(22):4420-8. PubMed ID: 17449150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemophilus influenzae type b conjugate vaccine is highly effective in the Ugandan routine immunization program: a case-control study.
    Lee EH; Lewis RF; Makumbi I; Kekitiinwa A; Ediamu TD; Bazibu M; Braka F; Flannery B; Zuber PL; Feikin DR
    Trop Med Int Health; 2008 Apr; 13(4):495-502. PubMed ID: 18312475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.